BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31350308)

  • 1. Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER.
    Wang M; Li E; Lin L; Kumar AK; Pan F; He L; Zhang J; Hu Z; Guo Z
    Mol Cancer Res; 2019 Oct; 17(10):2077-2088. PubMed ID: 31350308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.
    Nemec AA; Abriola L; Merkel JS; de Stanchina E; DeVeaux M; Zelterman D; Glazer PM; Sweasy JB
    Mol Cancer Res; 2017 Mar; 15(3):269-280. PubMed ID: 28074003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
    Yang J; Parsons J; Nicolay NH; Caporali S; Harrington CF; Singh R; Finch D; D'Atri S; Farmer PB; Johnston PG; McKenna WG; Dianov G; Sharma RA
    Oncogene; 2010 Jan; 29(3):463-8. PubMed ID: 19838217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of DNA polymerase beta in repairing oxidative damages induced by antitumor drug adriamycin.
    Liu S; Wu M; Zhang Z
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):163-70. PubMed ID: 20510258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Nucleotide Excision Repair in Cisplatin Resistance.
    Duan M; Ulibarri J; Liu KJ; Mao P
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G648C variant of DNA polymerase β sensitizes esophageal cancer to chemotherapy.
    Wang Y; Sun Q; Guo W; Chen X; Du Y; Zang W; Dong Z; Zhao G
    Tumour Biol; 2016 Feb; 37(2):1941-7. PubMed ID: 26334617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation.
    Raaphorst GP; Cybulski SE; Sobol R; Ng CE
    Anticancer Res; 2001; 21(3B):2079-83. PubMed ID: 11497301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents.
    Horton JK; Srivastava DK; Zmudzka BZ; Wilson SH
    Nucleic Acids Res; 1995 Oct; 23(19):3810-5. PubMed ID: 7479021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R152C DNA Pol β mutation impairs base excision repair and induces cellular transformation.
    Zhou T; Pan F; Cao Y; Han Y; Zhao J; Sun H; Zhou X; Wu X; He L; Hu Z; Chen H; Shen B; Guo Z
    Oncotarget; 2016 Feb; 7(6):6902-15. PubMed ID: 26760506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
    He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
    Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.
    Mukai M; Kanzaki A; Chen ZS; Miyashita H; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Takamatsu H; Akiyama S
    Oncol Rep; 2002; 9(4):839-44. PubMed ID: 12066219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells.
    Furuta T; Ueda T; Aune G; Sarasin A; Kraemer KH; Pommier Y
    Cancer Res; 2002 Sep; 62(17):4899-902. PubMed ID: 12208738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
    Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W; Zhang HL; Wu XM
    Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer-associated DNA polymerase β variant induces genomic instability and cellular transformation.
    Nemec AA; Donigan KA; Murphy DL; Jaeger J; Sweasy JB
    J Biol Chem; 2012 Jul; 287(28):23840-9. PubMed ID: 22573322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β.
    Wang Y; Feng J; Zang W; Du Y; Chen X; Sun Q; Dong Z; Zhao G
    Cell Physiol Biochem; 2015; 36(4):1587-96. PubMed ID: 26159783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of DNA polymerase beta-dependent base excision repair in response to oxidative stress in vivo.
    Cabelof DC; Raffoul JJ; Yanamadala S; Guo Z; Heydari AR
    Carcinogenesis; 2002 Sep; 23(9):1419-25. PubMed ID: 12189182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src-mediated phosphorylation of GAPDH regulates its nuclear localization and cellular response to DNA damage.
    Ci S; Xia W; Liang W; Qin L; Zhang Y; Dianov GL; Wang M; Zhao X; Wu C; Alagamuthu KK; Hu Z; He L; Pan F; Guo Z
    FASEB J; 2020 Aug; 34(8):10443-10461. PubMed ID: 32539222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.